Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs Clinical Use of Blood Drug Concentration Monitoring (JCS 2015)　― Digest Version ―-Reference-Cited by-同舟云学术

Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs Clinical Use of Blood Drug Concentration Monitoring (JCS 2015)　― Digest Version ―

Published:2017 Issue:4 Volume:81 Page:581-612
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Aonuma Kazutaka,Shiga Tsuyoshi,Atarashi Hirotsugu,Doki Kosuke,Echizen Hirotoshi,Hagiwara Nobuhisa,Hasegawa Junichi,Hayashi Hideharu,Hirao Kenzo,Ichida Fukiko,Ikeda Takanori,Maeda Yorinobu,Matsumoto Naoki,Sakaeda Toshiyuki,Shimizu Wataru,Sugawara Mitsuru,Totsuka Kyoichi,Tsuchishita Yoshimasa,Ueno Kazuyuki,Watanabe Eiichi,Hashiguchi Masayuki,Hirata Sumio,Kasai Hidefumi,Matsumoto Yoshiaki,Nogami Akihiko,Sekiguchi Yukio,Shinohara Tokuko,Sugiyama Atsushi,Sumitomo Naokata,Suzuki Atsushi,Takahashi Naohiko,Yukawa Eiji,Homma Masato,Horie Minoru,Inoue Hiroshi,Ito Hiroshi,Miura Takanori,Ohe Tohru,Shinozaki Kimikazu,Tanaka Kazuhiko,

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/81/4/81_CJ-66-0138/_pdf

Reference185 articles.

1. 1. The Japanese Society of Clinical Pharmacology and Therapeutics, editor. Clinical Pharmacology & Therapeutics, 3rd edn. Tokyo: Igaku Shoin, 2011 (in Japanese).

2. 2. Campbell TJ, Williams KM. Therapeutic drug monitoring: Antiarrhythmic drugs. Br J Clin Pharmacol 2001; 52(Suppl 1): 21S–34S.

3. 3. Boobis AR, Shiga T, Edwards RJ. Genetic polymorphisms and cardiovascular drug metabolism. In: Martin R Wilkins, editor. Cardiovascular pharmacogenetics. Springer-Verlag, 2003: 39–77.

4. 4. Aronson JK, Hardmann M. ABC of monitoring drug therapy: Measuring plasma drug concentrations. BMJ 1992; 305: 1078–1080.

5. 5. Ried LD, Horn JR, McKenna DA. Therapeutic drug monitoring reduces toxic drug reactions: A meta-analysis. Ther Drug Monit 1990; 12: 72–78.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A decision tree model for predicting high mono-N-desethylamiodarone concentrations and reducing tissue toxicity in patients with low-dose amiodarone therapy: A multicentral retrospective cohort study;Int. Journal of Clinical Pharmacology and Therapeutics;2024-09-01

2. Development, validation and long-term evaluation of a liquid chromatography-tandem mass spectrometry method for simultaneous quantification of amiodarone, desethylamiodarone and mexiletine in human plasma and serum;Journal of Chromatography B;2024-08

3. Flecainide Toxicity From Clinical Pharmacology Perspectives;Cureus;2024-07-31

4. Overview of therapeutic drug monitoring and clinical practice;Talanta;2024-01

5. Implications of Incorporating Plasma Lipoprotein Binding into a Physiologically‐Based Pharmacokinetic Model: A Simulation Study with Amiodarone;Clinical Pharmacology & Therapeutics;2023-12-26